Dr. Anurag Sharma, MD

Dr. Sharma practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Dr. Sharma's NPI, 1124391727, was assigned on February 14, 2012. Dr. Sharma graduated from Government Medical College Amritsar in 2009. Dr. Sharma holds New York license 307089.

Dr. Sharma's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961. The practice phone is (631) 751-3000.

Dr. Sharma's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dr. Sharma is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Sharma to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharma practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sharma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sharma is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sharma's licenses on file in 3 states: New York, Connecticut and New Jersey.

Dmand AI lists chronic anemia, chronic leukemia, lung cancer, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Sharma treats.

CMS data shows 2,352 Medicare services from Dr. Sharma across 29 procedure codes in 2024, for 334 Medicare patients. Medicare paid $75,388 for them.

CMS counts 334 Medicare patients who saw Dr. Sharma in 2024. The largest group is 75 to 84, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharma's median patient age at 56, with 67% women.

In 2024, Dr. Sharma wrote 528 Medicare Part D claims for 142 patients. 83% of them were for generic drugs. CMS names the drug for 368 of them, across 12 drugs with 11 or more claims each, at $404,236 in total drug cost. In 2023, CMS named 309 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sharma for performance year 2024, reported as part of a group. Dr. Sharma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sharma as offering telehealth.

Dmand AI links 9 papers to Dr. Sharma, published from 2011 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Lung, Pseudomonas aeruginosa and Pseudomonas Infections. Dr. Sharma's most frequent co-authors are Stefan Worgall, MD, PhD, Maged Mofied Ghaly, MD and Emile Gogineni, DO.

CMS Open Payments shows 149 general payments to Dr. Sharma from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Genentech, Inc. paid the most, $577.

Dr. Sharma graduated from Government Medical College Amritsar in 2009.

Dr. Sharma is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and MVP Health Care. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.